GoodRx Holdings, Inc.

Informe acción NasdaqGS:GDRX

Capitalización de mercado: US$2.7b

GoodRx Holdings Resultados de beneficios anteriores

Pasado controles de criterios 0/6

GoodRx Holdings ha aumentado sus beneficios a una tasa media anual de 1.8%, mientras que los beneficios de la industria de Healthcare Services han experimentado un crecimiento anual de 2.8%. Los ingresos han ido creciendo a una tasa media de 16.8% al año.

Información clave

1.8%

Tasa de crecimiento de los beneficios

-1.9%

Tasa de crecimiento del BPA

Crecimiento de la industria Healthcare Services 1.7%
Tasa de crecimiento de los ingresos16.8%
Rentabilidad financiera-1.2%
Margen neto-1.2%
Próxima actualización de resultados09 May 2024

Actualizaciones de resultados anteriores recientes

Recent updates

GoodRx Holdings: Large TAM Continues To Support Growth

Mar 20

GoodRx Holdings, Inc. (NASDAQ:GDRX) Stock Rockets 26% As Investors Are Less Pessimistic Than Expected

Mar 07
GoodRx Holdings, Inc. (NASDAQ:GDRX) Stock Rockets 26% As Investors Are Less Pessimistic Than Expected

Is GoodRx Holdings, Inc. (NASDAQ:GDRX) Trading At A 24% Discount?

Mar 01
Is GoodRx Holdings, Inc. (NASDAQ:GDRX) Trading At A 24% Discount?

GoodRx Holdings (NASDAQ:GDRX) Has A Rock Solid Balance Sheet

Feb 12
GoodRx Holdings (NASDAQ:GDRX) Has A Rock Solid Balance Sheet

GoodRx: Cost Saving Is A Strong Value Proposition To Consumers

Jan 23

GoodRx Holdings (NASDAQ:GDRX) May Have Issues Allocating Its Capital

Jan 22
GoodRx Holdings (NASDAQ:GDRX) May Have Issues Allocating Its Capital

GoodRx Stock Spikes After Receiving A Strong Dose Of Performance

Jan 11

What Is GoodRx Holdings, Inc.'s (NASDAQ:GDRX) Share Price Doing?

Dec 02
What Is GoodRx Holdings, Inc.'s (NASDAQ:GDRX) Share Price Doing?

GoodRx Holdings (NASDAQ:GDRX) May Have Issues Allocating Its Capital

Sep 12
GoodRx Holdings (NASDAQ:GDRX) May Have Issues Allocating Its Capital

An Intrinsic Calculation For GoodRx Holdings, Inc. (NASDAQ:GDRX) Suggests It's 41% Undervalued

Jul 14
An Intrinsic Calculation For GoodRx Holdings, Inc. (NASDAQ:GDRX) Suggests It's 41% Undervalued

GoodRx Holdings' (NASDAQ:GDRX) Returns On Capital Not Reflecting Well On The Business

May 27
GoodRx Holdings' (NASDAQ:GDRX) Returns On Capital Not Reflecting Well On The Business

Some Confidence Is Lacking In GoodRx Holdings, Inc. (NASDAQ:GDRX) As Shares Slide 27%

May 05
Some Confidence Is Lacking In GoodRx Holdings, Inc. (NASDAQ:GDRX) As Shares Slide 27%

Investors Give GoodRx Holdings, Inc. (NASDAQ:GDRX) Shares A 27% Hiding

May 05
Investors Give GoodRx Holdings, Inc. (NASDAQ:GDRX) Shares A 27% Hiding

Is There An Opportunity With GoodRx Holdings, Inc.'s (NASDAQ:GDRX) 45% Undervaluation?

Mar 23
Is There An Opportunity With GoodRx Holdings, Inc.'s (NASDAQ:GDRX) 45% Undervaluation?

GoodRx Holdings (NASDAQ:GDRX) May Have Issues Allocating Its Capital

Feb 07
GoodRx Holdings (NASDAQ:GDRX) May Have Issues Allocating Its Capital

GoodRx Holdings (NASDAQ:GDRX) Could Be Struggling To Allocate Capital

Nov 02
GoodRx Holdings (NASDAQ:GDRX) Could Be Struggling To Allocate Capital

GoodRx laying off 140 employees, 16% of workforce

Aug 31

GoodRx: Trending Positive, But Not A Buy Yet

Aug 25

GoodRx: Unexpected Short Squeeze As Grocer Issue Resolved

Aug 09

GoodRx: Unexpected Wrench Pushes Me To The Sidelines

Jul 25

Here's What's Concerning About GoodRx Holdings' (NASDAQ:GDRX) Returns On Capital

Jul 20
Here's What's Concerning About GoodRx Holdings' (NASDAQ:GDRX) Returns On Capital

GoodRx: Guidance Gets Worse, Stay Clear

May 19

GoodRx: Time To Buy The Dip

Apr 23

Returns On Capital Signal Tricky Times Ahead For GoodRx Holdings (NASDAQ:GDRX)

Apr 19
Returns On Capital Signal Tricky Times Ahead For GoodRx Holdings (NASDAQ:GDRX)

Desglose de ingresos y gastos
Beta

Cómo gana y gasta dinero GoodRx Holdings. Basado en los últimos beneficios reportados, en base a los últimos doce meses (LTM).


Historial de beneficios e ingresos

NasdaqGS:GDRX Ingresos, gastos y beneficios (USD Millions)
FechaIngresosBeneficiosGastos G+AGastos de I+D
31 Dec 23750-9451126
30 Sep 2373815418141
30 Jun 2374512427137
31 Mar 23747-48448141
31 Dec 22767-33465143
30 Sep 22796-71519141
30 Jun 22803-47515141
31 Mar 22788-15513135
31 Dec 21745-25525126
30 Sep 21686-282792114
30 Jun 21631-31483395
31 Mar 21578-31076478
31 Dec 20551-29471562
30 Sep 205101335748
30 Jun 204727523440
31 Mar 204355021734
31 Dec 193884219229
31 Dec 182501411344

Ingresos de calidad: GDRX is currently unprofitable.

Margen de beneficios creciente: GDRX is currently unprofitable.


Análisis del flujo de caja libre vs. Beneficios


Análisis del crecimiento de los beneficios en el pasado

Tendencia de beneficios: GDRX is unprofitable, but has reduced losses over the past 5 years at a rate of 1.8% per year.

Acelerando crecimiento: Unable to compare GDRX's earnings growth over the past year to its 5-year average as it is currently unprofitable

Beneficios vs. Industria: GDRX no es rentable, por lo que resulta difícil comparar el crecimiento de sus beneficios en el último año con el de la industria Healthcare Services (15.4%).


Rentabilidad financiera

Alta ROE: GDRX tiene una rentabilidad financiera negativa (-1.16%), ya que actualmente no es rentable.


Rentabilidad económica


Rendimiento del capital invertido


Descubre empresas con buenos resultados en el pasado

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target